Electrophoretic Deposition of Chitosan/Eudragit E 100/AgNPs Coatings for Controlled Release of Antibacterial Substance

Łukasz Pawłowski, A. Zieliński
{"title":"Electrophoretic Deposition of Chitosan/Eudragit E 100/AgNPs Coatings for Controlled Release of Antibacterial Substance","authors":"Łukasz Pawłowski, A. Zieliński","doi":"10.11159/icbes21.120","DOIUrl":null,"url":null,"abstract":"The development of bacterial infection of the tissues surrounding an implant is one of the leading causes of implant surgery failure. In order to prevent the deposition of bacteria on the implant surface and the formation of biofilm, coatings that exhibit antibacterial properties are manufactured. However, the problem is the controlled release of the therapeutic substance from the coating over the extended life of the implant [1], [2]. Usually, the active substance is released immediately when the implant is inserted into an environment simulating human body fluids, which results in burst release phenomenon, namely, the release of a large dose of active substance in a short period of time, which may result in a toxic effect. Unfortunately, chitosan, one of the most commonly used biopolymers in controlled drug delivery systems, is unstable in neutral pH environments, readily absorbs water, and swells, resulting in rapid release of the therapeutic agent. Therefore, it is necessary to limit the dissolution rate of the chitosan coating at neutral pH. Previous studies [3] have confirmed that the addition of Eudragit E 100, a cationic copolymer based on dimethylaminoethyl methacrylate, butyl methacrylate, and methyl methacrylate in a 2:1:1 ratio, to chitosan coatings significantly reduced the degradation of these coatings in artificial saliva solution at neutral pH while maintaining high sensitivity to pH drop. Hence, a biopolymer matrix of this type should provide a good carrier for an active substance, such as metallic nanoparticles with antibacterial activity, which will be released only when inflammation of peri-implant tissues occurs. The scientific objective of this study was to fabricate a smart composite coating of chitosan/Eudragit E 100/silver nanoparticles (chit/EE100/AgNPs) on grade 2 titanium surface using variable deposition parameters such as AgNPs concentration, voltage, and deposition time by the electrophoretic method. The determinant of the process of creating such composite coatings with EE100 by electrophoretic method on the surface of Ti grade 2 has not been determined yet. No publication concerning investigations of coatings containing chitosan/EE100 with silver nanoparticles has been found. The microstructure, surface roughness, thickness, chemical and phase composition, mechanical and electrochemical properties, silver release rate at different pH, and wettability of the produced coatings were investigated...","PeriodicalId":433404,"journal":{"name":"Proceedings of the 7th World Congress on Electrical Engineering and Computer Systems and Science","volume":"197 8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the 7th World Congress on Electrical Engineering and Computer Systems and Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11159/icbes21.120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The development of bacterial infection of the tissues surrounding an implant is one of the leading causes of implant surgery failure. In order to prevent the deposition of bacteria on the implant surface and the formation of biofilm, coatings that exhibit antibacterial properties are manufactured. However, the problem is the controlled release of the therapeutic substance from the coating over the extended life of the implant [1], [2]. Usually, the active substance is released immediately when the implant is inserted into an environment simulating human body fluids, which results in burst release phenomenon, namely, the release of a large dose of active substance in a short period of time, which may result in a toxic effect. Unfortunately, chitosan, one of the most commonly used biopolymers in controlled drug delivery systems, is unstable in neutral pH environments, readily absorbs water, and swells, resulting in rapid release of the therapeutic agent. Therefore, it is necessary to limit the dissolution rate of the chitosan coating at neutral pH. Previous studies [3] have confirmed that the addition of Eudragit E 100, a cationic copolymer based on dimethylaminoethyl methacrylate, butyl methacrylate, and methyl methacrylate in a 2:1:1 ratio, to chitosan coatings significantly reduced the degradation of these coatings in artificial saliva solution at neutral pH while maintaining high sensitivity to pH drop. Hence, a biopolymer matrix of this type should provide a good carrier for an active substance, such as metallic nanoparticles with antibacterial activity, which will be released only when inflammation of peri-implant tissues occurs. The scientific objective of this study was to fabricate a smart composite coating of chitosan/Eudragit E 100/silver nanoparticles (chit/EE100/AgNPs) on grade 2 titanium surface using variable deposition parameters such as AgNPs concentration, voltage, and deposition time by the electrophoretic method. The determinant of the process of creating such composite coatings with EE100 by electrophoretic method on the surface of Ti grade 2 has not been determined yet. No publication concerning investigations of coatings containing chitosan/EE100 with silver nanoparticles has been found. The microstructure, surface roughness, thickness, chemical and phase composition, mechanical and electrochemical properties, silver release rate at different pH, and wettability of the produced coatings were investigated...
壳聚糖/乌木聚糖e100 /AgNPs涂层的电泳沉积控制抗菌物质的释放
种植体周围组织细菌感染的发展是种植体手术失败的主要原因之一。为了防止细菌在种植体表面沉积和生物膜的形成,需要制造具有抗菌性能的涂层。然而,问题是在延长的种植体寿命期间,治疗物质从涂层中被控制释放[1],b[2]。通常情况下,植入物进入模拟人体体液的环境后,活性物质立即释放,产生爆裂释放现象,即在短时间内释放出大剂量的活性物质,可能产生毒性作用。不幸的是,壳聚糖是控制药物输送系统中最常用的生物聚合物之一,在中性pH环境中不稳定,容易吸水,膨胀,导致治疗剂快速释放。因此,有必要限制壳聚糖涂层在中性pH下的溶解速率。已有研究证实,在壳聚糖涂层中以2:1:1的比例加入Eudragit e100(一种基于甲基丙烯酸二甲胺乙酯、甲基丙烯酸丁酯和甲基丙烯酸甲酯的阳离子共聚物)可以显著降低壳聚糖涂层在中性pH下的人工唾液溶液中的降解,同时保持对pH下降的高敏感性。因此,这种类型的生物聚合物基质应该为活性物质提供良好的载体,例如具有抗菌活性的金属纳米颗粒,只有在种植体周围组织发生炎症时才会释放出来。本研究的科学目的是通过电泳法改变AgNPs浓度、电压和沉积时间等沉积参数,在2级钛表面制备壳聚糖/ e100 /银纳米颗粒(chit/EE100/AgNPs)的智能复合涂层。用电泳法在2级Ti表面制备EE100复合镀层的决定因素尚未确定。目前还没有关于壳聚糖/EE100纳米银涂层研究的出版物。考察了镀层的微观结构、表面粗糙度、厚度、化学和物相组成、力学和电化学性能、不同pH下银的释放速率和润湿性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信